1. Home
  2. BNR vs PFAI Comparison

BNR vs PFAI Comparison

Compare BNR & PFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • PFAI
  • Stock Information
  • Founded
  • BNR 2014
  • PFAI 2015
  • Country
  • BNR China
  • PFAI Canada
  • Employees
  • BNR N/A
  • PFAI N/A
  • Industry
  • BNR Medical Specialities
  • PFAI Farming/Seeds/Milling
  • Sector
  • BNR Health Care
  • PFAI Consumer Staples
  • Exchange
  • BNR Nasdaq
  • PFAI Nasdaq
  • Market Cap
  • BNR 38.3M
  • PFAI 20.6M
  • IPO Year
  • BNR 2020
  • PFAI 2025
  • Fundamental
  • Price
  • BNR $4.68
  • PFAI $1.94
  • Analyst Decision
  • BNR
  • PFAI
  • Analyst Count
  • BNR 0
  • PFAI 0
  • Target Price
  • BNR N/A
  • PFAI N/A
  • AVG Volume (30 Days)
  • BNR 17.4K
  • PFAI 232.5K
  • Earning Date
  • BNR 08-21-2025
  • PFAI 01-01-0001
  • Dividend Yield
  • BNR N/A
  • PFAI N/A
  • EPS Growth
  • BNR N/A
  • PFAI N/A
  • EPS
  • BNR N/A
  • PFAI 0.07
  • Revenue
  • BNR $72,112,038.00
  • PFAI $2,715,477.00
  • Revenue This Year
  • BNR $136.32
  • PFAI N/A
  • Revenue Next Year
  • BNR N/A
  • PFAI N/A
  • P/E Ratio
  • BNR N/A
  • PFAI $24.55
  • Revenue Growth
  • BNR 0.53
  • PFAI 1084.72
  • 52 Week Low
  • BNR $2.18
  • PFAI $1.55
  • 52 Week High
  • BNR $7.90
  • PFAI $4.40
  • Technical
  • Relative Strength Index (RSI)
  • BNR 69.57
  • PFAI N/A
  • Support Level
  • BNR $4.47
  • PFAI N/A
  • Resistance Level
  • BNR $4.96
  • PFAI N/A
  • Average True Range (ATR)
  • BNR 0.25
  • PFAI 0.00
  • MACD
  • BNR 0.11
  • PFAI 0.00
  • Stochastic Oscillator
  • BNR 84.31
  • PFAI 0.00

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About PFAI Pinnacle Food Group Limited Class A Common Shares

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups and are developing a hydroponic growing system for urban farms.

Share on Social Networks: